Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 224

1.

High-resolution genome-wide analysis is essential for the identification of ambiguous Aeromonas strains.

de Melo BST, Mendes-Marques CL, Campos TL, Almeida AMP, Leal NC, Xavier DE.

FEMS Microbiol Lett. 2019 Dec 5. pii: fnz245. doi: 10.1093/femsle/fnz245. [Epub ahead of print]

PMID:
31804685
2.

Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial.

Szarek M, Steg PG, DiCenso D, Bhatt DL, Bittner VA, Budaj A, Diaz R, Goodman SG, Gotcheva N, Jukema JW, Pordy R, Roe MT, Sourdille T, White HD, Xavier D, Zeiher AM, Schwartz GG.

Circ Cardiovasc Qual Outcomes. 2019 Nov;12(11):e005858. doi: 10.1161/CIRCOUTCOMES.119.005858. Epub 2019 Nov 11.

PMID:
31707826
3.

A novel plasmid-encoded mcr-4.3 gene in a colistin-resistant Acinetobacter baumannii clinical strain.

Martins-Sorenson N, Snesrud E, Xavier DE, Cacci LC, Iavarone AT, McGann P, Riley LW, Moreira BM.

J Antimicrob Chemother. 2020 Jan 1;75(1):60-64. doi: 10.1093/jac/dkz413.

PMID:
31578567
4.

Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.

Windecker S, Lopes RD, Massaro T, Jones-Burton C, Granger CB, Aronson R, Heizer G, Goodman SG, Darius H, Jones WS, Aschermann M, Brieger D, Cura F, Engstrøm T, Fridrich V, Halvorsen S, Huber K, Kang HJ, Leiva-Pons JL, Lewis BS, Malaga G, Meneveau N, Merkely B, Milicic D, Morais J, Potpara TS, Raev D, Sabaté M, de Waha-Thiele S, Welsh RC, Xavier D, Mehran R, Alexander JH; AUGUSTUS Investigators.

Circulation. 2019 Dec 3;140(23):1921-1932. doi: 10.1161/CIRCULATIONAHA.119.043308. Epub 2019 Sep 26.

PMID:
31557056
5.

Cardiovascular risk factor reduction by community health workers in rural India: A cluster randomized trial.

Joshi R, Agrawal T, Fathima F, Usha T, Thomas T, Misquith D, Kalantri S, Chidambaram N, Raj T, Singamani A, Hegde S, Xavier D, Devereaux PJ, Pais P, Gupta R, Yusuf S.

Am Heart J. 2019 Oct;216:9-19. doi: 10.1016/j.ahj.2019.06.007. Epub 2019 Jun 19.

PMID:
31377568
6.

Association between complications and death within 30 days after noncardiac surgery.

Vascular Events in Noncardiac Surgery Patients Cohort Evaluation (VISION) Study Investigators.

CMAJ. 2019 Jul 29;191(30):E830-E837. doi: 10.1503/cmaj.190221.

7.

The Healthfulness of the US Packaged Food and Beverage Supply: A Cross-Sectional Study.

Baldridge AS, Huffman MD, Taylor F, Xavier D, Bright B, Van Horn LV, Neal B, Dunford E.

Nutrients. 2019 Jul 24;11(8). pii: E1704. doi: 10.3390/nu11081704.

8.

[Analytical study of the breast cancer patient flow network in Brazil from 2014 to 2016].

Saldanha RF, Xavier DR, Carnavalli KM, Lerner K, Barcellos C.

Cad Saude Publica. 2019 Jul 22;35(7):e00090918. doi: 10.1590/0102-311X00090918. Portuguese.

9.

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.

Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators.

Lancet Diabetes Endocrinol. 2019 Aug;7(8):618-628. doi: 10.1016/S2213-8587(19)30158-5. Epub 2019 Jul 1. Erratum in: Lancet Diabetes Endocrinol. 2019 Jul 8;:. Lancet Diabetes Endocrinol. 2019 Sep;7(9):e21.

PMID:
31272931
10.

Rice susceptibility to root-knot nematodes is enhanced by the Meloidogyne incognita MSP18 effector gene.

Grossi-de-Sa M, Petitot AS, Xavier DA, Sá MEL, Mezzalira I, Beneventi MA, Martins NF, Baimey HK, Albuquerque EVS, Grossi-de-Sa MF, Fernandez D.

Planta. 2019 Oct;250(4):1215-1227. doi: 10.1007/s00425-019-03205-3. Epub 2019 Jun 19.

PMID:
31218413
11.

[Health Regions in Brazil based on hospital admissions: a method to support health regionalization].

Xavier DR, Oliveira RAD, Barcellos C, Saldanha RF, Ramalho WM, Laguardia J, Viacava F.

Cad Saude Publica. 2019 Jun 13;35Suppl 2(Suppl 2):e00076118. doi: 10.1590/0102-311X00076118. Portuguese.

12.

Spatial spread of malaria and economic frontier expansion in the Brazilian Amazon.

Souza PF, Xavier DR, Suarez Mutis MC, da Mota JC, Peiter PC, de Matos VP, Magalhães MAFM, Barcellos C.

PLoS One. 2019 Jun 18;14(6):e0217615. doi: 10.1371/journal.pone.0217615. eCollection 2019.

13.

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.

Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators.

Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9.

PMID:
31189511
14.

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.

Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators.

Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9.

PMID:
31189509
15.

From Samarco in Mariana to Vale in Brumadinho: mining dam disasters and Public Health.

Freitas CM, Barcellos C, Asmus CIRF, Silva MAD, Xavier DR.

Cad Saude Publica. 2019 May 20;35(5):e00052519. doi: 10.1590/0102-311X00052519. Portuguese, English. No abstract available.

16.

Prescription pattern, short-term outcomes, and its determinants in patients with chronic kidney disease attending a tertiary care hospital.

Mamadi RK, Sathish R, Selvaraj DR, Rathore R, Jose JV, Xavier D.

Indian J Pharmacol. 2019 Jan-Feb;51(1):55-60. doi: 10.4103/ijp.IJP_350_17.

17.

Characterization of the European Sea Bass (Dicentrarchus labrax) Gonadal Transcriptome During Sexual Development.

Ribas L, Crespo B, Sánchez-Baizán N, Xavier D, Kuhl H, Rodríguez JM, Díaz N, Boltañá S, MacKenzie S, Morán F, Zanuy S, Gómez A, Piferrer F.

Mar Biotechnol (NY). 2019 Jun;21(3):359-373. doi: 10.1007/s10126-019-09886-x. Epub 2019 Mar 27.

PMID:
30919121
18.

Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial.

Washam JB, Hohnloser SH, Lopes RD, Wojdyla DM, Vinereanu D, Alexander JH, Gersh BJ, Hanna M, Horowitz J, Hylek EM, Xavier D, Verheugt FWA, Wallentin L, Granger CB; ARISTOTLE Committees and Investigators.

J Thromb Thrombolysis. 2019 Apr;47(3):345-352. doi: 10.1007/s11239-019-01823-y.

PMID:
30790160
19.

Effect of intensive lifestyle modification & metformin on cardiovascular risk in prediabetes: A pilot randomized control trial.

Kulkarni S, Xavier D, George B, Umesh S, Fathima S, Bantwal G.

Indian J Med Res. 2018 Dec;148(6):705-712. doi: 10.4103/ijmr.IJMR_1201_17.

20.

Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's disease.

de Andrade P, Mantoani SP, Gonçalves Nunes PS, Magadán CR, Pérez C, Xavier DJ, Hojo ETS, Campillo NE, Martínez A, Carvalho I.

Bioorg Med Chem. 2019 Mar 15;27(6):931-943. doi: 10.1016/j.bmc.2018.12.030. Epub 2018 Dec 23.

PMID:
30765302

Supplemental Content

Loading ...
Support Center